The determination of cell-specific signatures allowed for a classification of the SLE patients, ND and immunised ND (Figure 3A for the CD4+ T cells, Figure 3B for the CD16− monocytes and Figure 3C for the CD16+ monocytes). This evidence concerns the gene CD4 and systemic lupus erythematosus.